Author Correction: Jawsamycin exhibits in vivo antifungal properties by inhibiting Spt14/Gpi3-mediated biosynthesis of glycosylphosphatidylinositol (Nature Communications, (2020), 11, 1, (3387), 10.1038/s41467-020-17221-5)

Yue Fu; David Estoppey; Silvio Roggo; Dominik Pistorius; Florian Fuchs; Christian Studer; Ashraf S. Ibrahim; Thomas Aust; Frederic Grandjean; Manuel Mihalic; Klaus Memmert; Vivian Prindle; Etienne Richard; Ralph Riedl; Sven Schuierer; Eric Weber; Jürg Hunziker; Frank Petersen; Jianshi Tao; Dominic Hoepfner

ArticleOPEN ACCESS

Author Correction: Jawsamycin exhibits in vivo antifungal properties by inhibiting Spt14/Gpi3-mediated biosynthesis of glycosylphosphatidylinositol (Nature Communications, (2020), 11, 1, (3387), 10.1038/s41467-020-17221-5)

Fu Y
Estoppey D
Roggo S
et al.

Nature Communications

DOI: 10.1038/s41467-020-17748-7

1Citations

10Readers

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Cite

CITATION STYLE

APA

Fu, Y., Estoppey, D., Roggo, S., Pistorius, D., Fuchs, F., Studer, C., … Hoepfner, D. (2020, December 1). Author Correction: Jawsamycin exhibits in vivo antifungal properties by inhibiting Spt14/Gpi3-mediated biosynthesis of glycosylphosphatidylinositol (Nature Communications, (2020), 11, 1, (3387), 10.1038/s41467-020-17221-5). Nature Communications. Nature Research. https://doi.org/10.1038/s41467-020-17748-7

Author Correction: Jawsamycin exhibits in vivo antifungal properties by inhibiting Spt14/Gpi3-mediated biosynthesis of glycosylphosphatidylinositol (Nature Communications, (2020), 11, 1, (3387), 10.1038/s41467-020-17221-5)

Abstract

Cite

Register to see more suggestions